RECRUITING

Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia

Talk to us

Conditions

Coronary Artery DiseaseMyocardial InfarctionExercise induced ischemia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to observe the effects of treatment from a device called the Bioboosti which utilizes pulsed electromagnetic waves on its ability to improve blood flow to the heart tissue in individuals with coronary artery disease (CAD).

Official Title

Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia

Quick Facts

Study Start:2022-05-18
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05111288

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years old.
  2. * Known cardiac ischemia, who are non revascularizable, or have not and will not be undergo coronary intervention for the duration of their participation in the study.
  3. * Evidence of ischemia from previous clinical tests (echo, nuclear, standard ECG from past 6 months).
  4. * Left Ventricular Ejection fraction \> 40% by echo (evaluated last 3 months).
  5. * Able to complete a cardiopulmonary exercise test without significant non cardiac limitations, primarily orthopedic.
  6. * On guideline directed optimal therapy for stable ischemia.
  1. * Anemia (\< 7 mg/dl).
  2. * Low potassium (\< 3 mmol/L).
  3. * Creatinine (\> 5.0 mg/dl or \< 0.6 mg/dl).
  4. * Unable to exercise due primarily to orthopedic limitation.
  5. * Severe lung disease.
  6. * Morbid obesity (BMI \> 42).
  7. * Pregnant.
  8. * Breast feeding.
  9. * Significant arrhythmia (ventricular tachycardia, ventricular fibrillation, frequent premature ventricular contractions (PVCs), persistent atrial fibrillation, or 2nd or 3rd degree atrioventricular (AV) block).
  10. * Seizures.
  11. * Unstable angina.
  12. * Coronary spasm.
  13. * Recent myocardial infarction (\< 90 days).
  14. * Recent percutaneous coronary intervention (\<90 days).

Contacts and Locations

Principal Investigator

Courtney Wheatley-Guy, PhD
PRINCIPAL_INVESTIGATOR
Mayo Clinic
Bruce Johnson, PhD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Arizona
Scottsdale, Arizona, 85259
United States
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Courtney Wheatley-Guy, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic
  • Bruce Johnson, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-18
Study Completion Date2025-11

Study Record Updates

Study Start Date2022-05-18
Study Completion Date2025-11

Terms related to this study

Keywords Provided by Researchers

  • Exercise induced ischemia

Additional Relevant MeSH Terms

  • Coronary Artery Disease
  • Myocardial Infarction